The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in Sweden

Value Health. 2014 Nov;17(7):A598-9. doi: 10.1016/j.jval.2014.08.2070. Epub 2014 Oct 26.
No abstract available